iBio Inc. | |
Stock Exchange | NYSE |
EPS |
$1.06 |
Market Cap |
$13.59 M |
Shares Outstanding |
19.7 M |
Public Float |
17.95 M |
Address |
600 Madison Avenue New York New York 10022 United States |
Employees | - |
Website | http://www.ibioinc.com |
Updated | 07/08/2019 |
iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals. |